{
    "clinical_study": {
        "@rank": "92293", 
        "arm_group": [
            {
                "arm_group_label": "No ring - condom only", 
                "arm_group_type": "No Intervention"
            }, 
            {
                "arm_group_label": "placebo vaginal ring", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Female condom used with vaginal ring"
            }
        ], 
        "brief_summary": {
            "textblock": "Trial being conducted to assess the total clinical failure rate and its components of a\n      female condom used during vaginal intercourse in the presence and absence of the vaginal\n      ring."
        }, 
        "brief_title": "Female Condom Functionality", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Condom Functionality", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Mutually monogamous heterosexual couples; current relationship \u22653 months; and who can\n             give written informed consent;\n\n          2. Age \u226518 to \u226445 years (females) or \u226518 to \u226455 years (males) at time of the screening\n             visit;\n\n          3. Healthy on the basis of medical history;\n\n          4. Not at risk of pregnancy, i.e., female is surgically sterile, using an IUD, or using\n             effective hormonal contraception, or has a vasectomized partner. The use of vaginal\n             contraceptive rings will not be allowed;\n\n          5. Sexually active and agree to have at least 8 acts of penile-vaginal intercourse using\n             a study condom over 2 periods of up to 4 weeks each;\n\n          6. Agree to use only the female condoms provided by trial personnel during the time of\n             participation and not to use male condoms during the trial.  Additional lubricant\n             will be provided; use of non-study lubricants will not be allowed;\n\n          7. Agree to not use genital jewelry or other vaginal products, except menstrual\n             absorption products (e.g., tampons) and study lubricant during the trial;\n\n          8. Available for all visits and consent to follow all procedures scheduled for the\n             trial;\n\n          9. At low risk for HIV infection.\n\n        Exclusion Criteria:\n\n          1. Males with untreated erectile dysfunction;\n\n          2. Female with positive pregnancy test;\n\n          3. Either partner allergic or hypersensitive to vaginal lubricants such as Astorlige \u00ae\n\n          4. Either partner not willing to refrain from wearing  genital piercing jewelry for the\n             duration of the study\n\n          5. History by self-report of recurrent or a recently-treated (within past 2 weeks)\n             sexually transmitted infection (e.g. gonorrhea, syphilis, chlamydia) or HIV(+);\n\n          6. Consistently using male or female condoms for protection against sexually transmitted\n             infection;\n\n          7. Either partner taking any topical or oral medication to treat a urogenital condition\n             at enrollment, except medication for the male partner to treat erectile dysfunction\n             (e.g., tadalafil, sildenafil);\n\n          8. Either partner with a self-reported or clinically diagnosed urogenital condition\n             (e.g. itching, burning, irritation, etc.) that, in the opinion of the Investigator,\n             could affect use of the study condoms or ability to interpret trial data;\n\n          9. Females, based on findings from a pelvic examination, who are not suitable candidates\n             for wearing the vaginal ring (anatomical condition, current vaginal infection, etc.)\n\n         10. Current participation in a study or other research involving a drug, device or other\n             product;\n\n         11. Any condition(s) that, in the opinion of the Investigator, might interfere with\n             adherence to trial requirements or evaluation of the trial objectives."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01755754", 
            "org_study_id": "IPM 033"
        }, 
        "intervention": {
            "arm_group_label": "placebo vaginal ring", 
            "intervention_name": "vaginal ring", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "December 2, 2013", 
        "location": {
            "contact": {
                "last_name": "Seline Guidotti", 
                "phone": "877-437-2007"
            }, 
            "contact_backup": {
                "last_name": "Kate Hodges", 
                "phone": "800-300-5767"
            }, 
            "facility": {
                "address": {
                    "city": "Los Angeles", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "90010"
                }, 
                "name": "California Family Health Council"
            }, 
            "investigator": {
                "last_name": "Ron Frezieres", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multicenter, Open-label, Randomized, Two-period, Crossover Non-inferiority Trial to Assess the FunctionalityY of Female Condoms With a Silicone Elastomer Vaginal Ring", 
        "overall_contact": {
            "email": "frezieres@cfhc.org", 
            "last_name": "Ron Frezieres", 
            "phone": "213-386-5614", 
            "phone_ext": "4403"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Total clinical failure rate", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01755754"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "International Partnership for Microbicides, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "International Partnership for Microbicides, Inc.", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}